Quaker Chemical Valuation
Is QUC undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of QUC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: QUC (€176) is trading below our estimate of fair value (€346.33)
Significantly Below Fair Value: QUC is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for QUC?
Other financial metrics that can be useful for relative valuation.
What is QUC's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$3.42b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2.1x |
Enterprise Value/EBITDA | 13.3x |
PEG Ratio | 1.4x |
Price to Earnings Ratio vs Peers
How does QUC's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 22.3x | ||
WCH Wacker Chemie | 23.7x | 29.6% | €5.0b |
SY1 Symrise | 41.1x | 15.6% | €14.0b |
ACT AlzChem Group | 13.3x | 12.6% | €461.0m |
UZU Uzin Utz | 11.1x | 6.7% |